Scutellarin, a flavonoid glucuronide, is an active ingredient of breviscapine. It can be widely used in the treatment of cerebral infarction, coronary heart disease and angina pectoris.
The global Scutellarin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Plant sources include the leaves of Scutellaria altissima L, the stem and leaves of Scutellaria altissima L, and the whole herb of Scutellaria altissima (S. Barbara D. Don). It has the functions of reducing cerebrovascular resistance, improving cerebral blood circulation, increasing cerebral blood flow and anti-platelet aggregation. It is clinically used for the treatment of paralysis after cerebrovascular disease.
This report aims to provide a comprehensive presentation of the global market for Scutellarin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scutellarin.
Report Scope
The Scutellarin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Scutellarin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Scutellarin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pu RuiSi
YuanYe
J&K
Xi Li
Pu RuiFa
DaoLan
TongTian
Target Mol
Rui FenSi
Bidel
MacLin
KangNuo
Solarbio
HeGu
Boc Sciences
TargetMol
Cayman Chemical Company
Matrix Scientific
JR MediChem
ChemScene
CSNpharm
Cfm Oskar Tropitzsch
GLR Innovations
Carbosynth
Leancare
Apin Chemicals
Segment by Type
98% Purity
99% Purity
Segment by Application
Medical
Life Sciences
Health Products
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Scutellarin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Scutellarin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scutellarin Market Overview
1.1 Product Overview and Scope of Scutellarin
1.2 Scutellarin Segment by Type
1.2.1 Global Scutellarin Market Value Comparison by Type (2024-2030)
1.2.2 98% Purity
1.2.3 99% Purity
1.3 Scutellarin Segment by Application
1.3.1 Global Scutellarin Market Value by Application: (2024-2030)
1.3.2 Medical
1.3.3 Life Sciences
1.3.4 Health Products
1.4 Global Scutellarin Market Size Estimates and Forecasts
1.4.1 Global Scutellarin Revenue 2019-2030
1.4.2 Global Scutellarin Sales 2019-2030
1.4.3 Global Scutellarin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Scutellarin Market Competition by Manufacturers
2.1 Global Scutellarin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Scutellarin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Scutellarin Average Price by Manufacturers (2019-2024)
2.4 Global Scutellarin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Scutellarin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Scutellarin, Product Type & Application
2.7 Scutellarin Market Competitive Situation and Trends
2.7.1 Scutellarin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Scutellarin Players Market Share by Revenue
2.7.3 Global Scutellarin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Scutellarin Retrospective Market Scenario by Region
3.1 Global Scutellarin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Scutellarin Global Scutellarin Sales by Region: 2019-2030
3.2.1 Global Scutellarin Sales by Region: 2019-2024
3.2.2 Global Scutellarin Sales by Region: 2025-2030
3.3 Global Scutellarin Global Scutellarin Revenue by Region: 2019-2030
3.3.1 Global Scutellarin Revenue by Region: 2019-2024
3.3.2 Global Scutellarin Revenue by Region: 2025-2030
3.4 North America Scutellarin Market Facts & Figures by Country
3.4.1 North America Scutellarin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Scutellarin Sales by Country (2019-2030)
3.4.3 North America Scutellarin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Scutellarin Market Facts & Figures by Country
3.5.1 Europe Scutellarin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Scutellarin Sales by Country (2019-2030)
3.5.3 Europe Scutellarin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Scutellarin Market Facts & Figures by Country
3.6.1 Asia Pacific Scutellarin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Scutellarin Sales by Country (2019-2030)
3.6.3 Asia Pacific Scutellarin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Scutellarin Market Facts & Figures by Country
3.7.1 Latin America Scutellarin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Scutellarin Sales by Country (2019-2030)
3.7.3 Latin America Scutellarin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Scutellarin Market Facts & Figures by Country
3.8.1 Middle East and Africa Scutellarin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Scutellarin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Scutellarin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Scutellarin Sales by Type (2019-2030)
4.1.1 Global Scutellarin Sales by Type (2019-2024)
4.1.2 Global Scutellarin Sales by Type (2025-2030)
4.1.3 Global Scutellarin Sales Market Share by Type (2019-2030)
4.2 Global Scutellarin Revenue by Type (2019-2030)
4.2.1 Global Scutellarin Revenue by Type (2019-2024)
4.2.2 Global Scutellarin Revenue by Type (2025-2030)
4.2.3 Global Scutellarin Revenue Market Share by Type (2019-2030)
4.3 Global Scutellarin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Scutellarin Sales by Application (2019-2030)
5.1.1 Global Scutellarin Sales by Application (2019-2024)
5.1.2 Global Scutellarin Sales by Application (2025-2030)
5.1.3 Global Scutellarin Sales Market Share by Application (2019-2030)
5.2 Global Scutellarin Revenue by Application (2019-2030)
5.2.1 Global Scutellarin Revenue by Application (2019-2024)
5.2.2 Global Scutellarin Revenue by Application (2025-2030)
5.2.3 Global Scutellarin Revenue Market Share by Application (2019-2030)
5.3 Global Scutellarin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pu RuiSi
6.1.1 Pu RuiSi Corporation Information
6.1.2 Pu RuiSi Description and Business Overview
6.1.3 Pu RuiSi Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pu RuiSi Scutellarin Product Portfolio
6.1.5 Pu RuiSi Recent Developments/Updates
6.2 YuanYe
6.2.1 YuanYe Corporation Information
6.2.2 YuanYe Description and Business Overview
6.2.3 YuanYe Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 YuanYe Scutellarin Product Portfolio
6.2.5 YuanYe Recent Developments/Updates
6.3 J&K
6.3.1 J&K Corporation Information
6.3.2 J&K Description and Business Overview
6.3.3 J&K Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 J&K Scutellarin Product Portfolio
6.3.5 J&K Recent Developments/Updates
6.4 Xi Li
6.4.1 Xi Li Corporation Information
6.4.2 Xi Li Description and Business Overview
6.4.3 Xi Li Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Xi Li Scutellarin Product Portfolio
6.4.5 Xi Li Recent Developments/Updates
6.5 Pu RuiFa
6.5.1 Pu RuiFa Corporation Information
6.5.2 Pu RuiFa Description and Business Overview
6.5.3 Pu RuiFa Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pu RuiFa Scutellarin Product Portfolio
6.5.5 Pu RuiFa Recent Developments/Updates
6.6 DaoLan
6.6.1 DaoLan Corporation Information
6.6.2 DaoLan Description and Business Overview
6.6.3 DaoLan Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 DaoLan Scutellarin Product Portfolio
6.6.5 DaoLan Recent Developments/Updates
6.7 TongTian
6.6.1 TongTian Corporation Information
6.6.2 TongTian Description and Business Overview
6.6.3 TongTian Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 TongTian Scutellarin Product Portfolio
6.7.5 TongTian Recent Developments/Updates
6.8 Target Mol
6.8.1 Target Mol Corporation Information
6.8.2 Target Mol Description and Business Overview
6.8.3 Target Mol Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Target Mol Scutellarin Product Portfolio
6.8.5 Target Mol Recent Developments/Updates
6.9 Rui FenSi
6.9.1 Rui FenSi Corporation Information
6.9.2 Rui FenSi Description and Business Overview
6.9.3 Rui FenSi Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Rui FenSi Scutellarin Product Portfolio
6.9.5 Rui FenSi Recent Developments/Updates
6.10 Bidel
6.10.1 Bidel Corporation Information
6.10.2 Bidel Description and Business Overview
6.10.3 Bidel Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bidel Scutellarin Product Portfolio
6.10.5 Bidel Recent Developments/Updates
6.11 MacLin
6.11.1 MacLin Corporation Information
6.11.2 MacLin Scutellarin Description and Business Overview
6.11.3 MacLin Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MacLin Scutellarin Product Portfolio
6.11.5 MacLin Recent Developments/Updates
6.12 KangNuo
6.12.1 KangNuo Corporation Information
6.12.2 KangNuo Scutellarin Description and Business Overview
6.12.3 KangNuo Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 KangNuo Scutellarin Product Portfolio
6.12.5 KangNuo Recent Developments/Updates
6.13 Solarbio
6.13.1 Solarbio Corporation Information
6.13.2 Solarbio Scutellarin Description and Business Overview
6.13.3 Solarbio Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Solarbio Scutellarin Product Portfolio
6.13.5 Solarbio Recent Developments/Updates
6.14 HeGu
6.14.1 HeGu Corporation Information
6.14.2 HeGu Scutellarin Description and Business Overview
6.14.3 HeGu Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 HeGu Scutellarin Product Portfolio
6.14.5 HeGu Recent Developments/Updates
6.15 Boc Sciences
6.15.1 Boc Sciences Corporation Information
6.15.2 Boc Sciences Scutellarin Description and Business Overview
6.15.3 Boc Sciences Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Boc Sciences Scutellarin Product Portfolio
6.15.5 Boc Sciences Recent Developments/Updates
6.16 TargetMol
6.16.1 TargetMol Corporation Information
6.16.2 TargetMol Scutellarin Description and Business Overview
6.16.3 TargetMol Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.16.4 TargetMol Scutellarin Product Portfolio
6.16.5 TargetMol Recent Developments/Updates
6.17 Cayman Chemical Company
6.17.1 Cayman Chemical Company Corporation Information
6.17.2 Cayman Chemical Company Scutellarin Description and Business Overview
6.17.3 Cayman Chemical Company Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Cayman Chemical Company Scutellarin Product Portfolio
6.17.5 Cayman Chemical Company Recent Developments/Updates
6.18 Matrix Scientific
6.18.1 Matrix Scientific Corporation Information
6.18.2 Matrix Scientific Scutellarin Description and Business Overview
6.18.3 Matrix Scientific Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Matrix Scientific Scutellarin Product Portfolio
6.18.5 Matrix Scientific Recent Developments/Updates
6.19 JR MediChem
6.19.1 JR MediChem Corporation Information
6.19.2 JR MediChem Scutellarin Description and Business Overview
6.19.3 JR MediChem Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.19.4 JR MediChem Scutellarin Product Portfolio
6.19.5 JR MediChem Recent Developments/Updates
6.20 ChemScene
6.20.1 ChemScene Corporation Information
6.20.2 ChemScene Scutellarin Description and Business Overview
6.20.3 ChemScene Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.20.4 ChemScene Scutellarin Product Portfolio
6.20.5 ChemScene Recent Developments/Updates
6.21 CSNpharm
6.21.1 CSNpharm Corporation Information
6.21.2 CSNpharm Scutellarin Description and Business Overview
6.21.3 CSNpharm Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.21.4 CSNpharm Scutellarin Product Portfolio
6.21.5 CSNpharm Recent Developments/Updates
6.22 Cfm Oskar Tropitzsch
6.22.1 Cfm Oskar Tropitzsch Corporation Information
6.22.2 Cfm Oskar Tropitzsch Scutellarin Description and Business Overview
6.22.3 Cfm Oskar Tropitzsch Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Cfm Oskar Tropitzsch Scutellarin Product Portfolio
6.22.5 Cfm Oskar Tropitzsch Recent Developments/Updates
6.23 GLR Innovations
6.23.1 GLR Innovations Corporation Information
6.23.2 GLR Innovations Scutellarin Description and Business Overview
6.23.3 GLR Innovations Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.23.4 GLR Innovations Scutellarin Product Portfolio
6.23.5 GLR Innovations Recent Developments/Updates
6.24 Carbosynth
6.24.1 Carbosynth Corporation Information
6.24.2 Carbosynth Scutellarin Description and Business Overview
6.24.3 Carbosynth Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Carbosynth Scutellarin Product Portfolio
6.24.5 Carbosynth Recent Developments/Updates
6.25 Leancare
6.25.1 Leancare Corporation Information
6.25.2 Leancare Scutellarin Description and Business Overview
6.25.3 Leancare Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Leancare Scutellarin Product Portfolio
6.25.5 Leancare Recent Developments/Updates
6.26 Apin Chemicals
6.26.1 Apin Chemicals Corporation Information
6.26.2 Apin Chemicals Scutellarin Description and Business Overview
6.26.3 Apin Chemicals Scutellarin Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Apin Chemicals Scutellarin Product Portfolio
6.26.5 Apin Chemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Scutellarin Industry Chain Analysis
7.2 Scutellarin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Scutellarin Production Mode & Process
7.4 Scutellarin Sales and Marketing
7.4.1 Scutellarin Sales Channels
7.4.2 Scutellarin Distributors
7.5 Scutellarin Customers
8 Scutellarin Market Dynamics
8.1 Scutellarin Industry Trends
8.2 Scutellarin Market Drivers
8.3 Scutellarin Market Challenges
8.4 Scutellarin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Pu RuiSi
YuanYe
J&K
Xi Li
Pu RuiFa
DaoLan
TongTian
Target Mol
Rui FenSi
Bidel
MacLin
KangNuo
Solarbio
HeGu
Boc Sciences
TargetMol
Cayman Chemical Company
Matrix Scientific
JR MediChem
ChemScene
CSNpharm
Cfm Oskar Tropitzsch
GLR Innovations
Carbosynth
Leancare
Apin Chemicals
听
听
*If Applicable.